HOB: Clinically Indicated PIVs - A Need for Increased Surveillance

With over four decades of experience spanning ICU, OR, infusion therapy, and oncology in both adult and pediatric care, Laurie has dedicated her career to advancing vascular access practice, policy, and education. She has served as a member and author of the INS Infusion Therapy Standards of Practice Committee, chaired AVA’s Public Policy efforts, contributed to the newly released textbook Vessel Health and Preservation, and held leadership roles with INS and industry partners. Her expertise in clinical practice, health economics, and team building has shaped hospital, outpatient, and home infusion programs across the nation.

Learning Objectives:

• Discuss the origins and impact of Hospital-Onset Bacteremia (HOB) as a quality measure.
• Describe changes in standards, practice, and policies for managing and mitigating complications associated with Peripheral IVs (PIVs) and Difficult IV Access (DIVA) patients.
• Appraise regulatory focus regarding Ultrasound Guided Peripheral IVs (USGPIV).
• Articulate the value of an interdisciplinary approach to PIV practice and policy.